Laura Detti

review 2026

The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy

Journal of assisted reproduction and genetics ·doi:10.1007/s10815-026-03941-y

PURPOSE: Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-in…

article 2024

Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis

Endocrinology ·doi:10.1210/endocr/bqae003

Endometriosis is a common and debilitating disease, affecting ∼170 million women worldwide. Affected patients have limited therapeutic options such as hormonal suppression or surgical excision of the lesions, though therapies are often not …

article 2024

MILD ADENOMYOSIS DOES NOT IMPACT PREGNANCY RATE OR PREGNANCY OUTCOMES IN SINGLE EUPLOID FROZEN EMBRYO TRANSFERS

·doi:10.1016/j.fertnstert.2024.07.929

book-chapter 2022

Reproductive Imaging

·doi:10.1007/978-3-030-99596-6_5

article 2019

Redundant endometrium and endometrial polyps: is there a link?

·doi:10.1016/j.fertnstert.2019.07.959

article 2014

Altered redox state in the endometrium of patients undergoing ovarian stimulation for assisted reproduction technology

·doi:10.1016/j.fertnstert.2014.07.949